Patients tend to trust that the drugs they need to take for their health issues have been through proper quality control procedures and are safe for use. A recent recall of a popular at home dialysis drug has patients across the country, including some in Ohio, questioning the liability of the manufacturer. In cases where an injury resulted from using this apparently tainted drug, pharmaceutical litigation may follow.
America, as a whole, has seen an increase in not only the number of patients using prescribed painkillers, but in the number of painkillers currently manufactured by pharmaceutical companies. With every new drug that comes out, experts grow increasing concerned about possible drug injuries that may result from their use. Ohio residents, who have suffered injuries related to prescription use, retain the right to file a lawsuit to seek compensation for the damages done.
Ohio residents who rely on the antidepressant called Effexor XR or generic versions of the drug should be aware that three lots of the medication were recently recalled by its manufacturer, Pfizer Inc. According to the report, the recall resulted after the discovery of a single capsule of another medication in a bottle of Effexor.
Army personnel from Ohio and other states have been ordered by the Surgeon General's Office of the Army Special Operations Command to stop using a drug that may induce permanent brain damage. The drug, known as mefloquine, was specifically designed by the Army during the 1970s as way to fight malaria, and its usage has spread to millions of travelers who were never in the military because of its low cost and ease of use.
When drug giant Pfizer acquired Wyeth Pharmaceuticals in 2009, they also acquired a very large criminal and civil liability. According to the U.S. Department of Justice, Wyeth improperly marketed and mis-branded their drug Rapamune, approved in 2009 by the U.S. Food and Drug Administration for use by kidney transplant patients in Ohio and across the nation.
Ohio residents may be interested to learn that while the Food and Drug Administration (FDA) oversees all pharmaceutical drugs produced and distributed in the United States, it appears that the FDA and international organizations are finding law enforcement more difficult in cyberspace. As buyers seek out cheaper alternatives to purchasing medication in drug stores and pharmacies around the nation, online pharmacies are increasing their presence to take advantage of the available consumer base.
Interest groups were putting pressure on the White House to compete its final safety review on medical device identifiers. Premier healthcare alliance, which represents purchasers of devices, and The Pew Charitable Trusts, a research organization, were asking the White House Office of Management and Budget, or OMB, to make a final decision concerning the Food and Drug Administration rule. The groups claim that the FDA missed a statutory deadline; they insist that the decision is necessary in order to provide safety and quality improvements regarding patient care in Ohio and all over the United States.